RU2656186C2 - Вирус гриппа с и вакцина - Google Patents

Вирус гриппа с и вакцина Download PDF

Info

Publication number
RU2656186C2
RU2656186C2 RU2014134850A RU2014134850A RU2656186C2 RU 2656186 C2 RU2656186 C2 RU 2656186C2 RU 2014134850 A RU2014134850 A RU 2014134850A RU 2014134850 A RU2014134850 A RU 2014134850A RU 2656186 C2 RU2656186 C2 RU 2656186C2
Authority
RU
Russia
Prior art keywords
virus
influenza
swine influenza
sample
tube
Prior art date
Application number
RU2014134850A
Other languages
English (en)
Russian (ru)
Other versions
RU2014134850A (ru
Inventor
Рэнди Р. Симонсон
Эмили А. КОЛЛИН
Бенджамин М. Хаус
Original Assignee
Ньюпорт Лабораториз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ньюпорт Лабораториз, Инк. filed Critical Ньюпорт Лабораториз, Инк.
Publication of RU2014134850A publication Critical patent/RU2014134850A/ru
Application granted granted Critical
Publication of RU2656186C2 publication Critical patent/RU2656186C2/ru

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16311—Influenzavirus C, i.e. influenza C virus
    • C12N2760/16321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16311—Influenzavirus C, i.e. influenza C virus
    • C12N2760/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16311—Influenzavirus C, i.e. influenza C virus
    • C12N2760/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
RU2014134850A 2012-01-27 2013-01-28 Вирус гриппа с и вакцина RU2656186C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/385,004 2012-01-27
US13/385,004 US9278999B2 (en) 2012-01-27 2012-01-27 Influenza C virus and vaccine
PCT/US2013/023441 WO2013112995A1 (en) 2012-01-27 2013-01-28 Influenza c virus and vaccine

Publications (2)

Publication Number Publication Date
RU2014134850A RU2014134850A (ru) 2016-03-20
RU2656186C2 true RU2656186C2 (ru) 2018-05-31

Family

ID=47714564

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2014134850A RU2656186C2 (ru) 2012-01-27 2013-01-28 Вирус гриппа с и вакцина

Country Status (13)

Country Link
US (1) US9278999B2 (enExample)
EP (1) EP2807184A1 (enExample)
JP (1) JP6257529B2 (enExample)
CN (1) CN104203972A (enExample)
AU (1) AU2013211833B2 (enExample)
BR (1) BR112014018278B1 (enExample)
CA (1) CA2862328C (enExample)
HK (1) HK1201283A1 (enExample)
MX (1) MX360831B (enExample)
NZ (1) NZ629378A (enExample)
PH (1) PH12014501688A1 (enExample)
RU (1) RU2656186C2 (enExample)
WO (1) WO2013112995A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2879443A1 (en) * 2012-07-19 2014-01-23 Zoetis Llc Bovine influenza virus compositions
AR111770A1 (es) 2017-05-05 2019-08-21 Elanco Us Inc Vacuna para enfermedad respiratoria bovina
CN111363855A (zh) * 2020-04-30 2020-07-03 山东省农业科学院家禽研究所（山东省无特定病原鸡研究中心） 一种同时检测a、d型流感病毒的成套试剂、试剂盒及其应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2428476C1 (ru) * 2010-06-21 2011-09-10 Учреждение Российской Академии Медицинских Наук Научно-исследовательский институт экспериментальной медицины Северо-западного отделения РАМН (НИИЭМ СЗО РАМН) Реассортантный штамм вируса гриппа rn 1/09-swine a(h7n1) для определения антител к нейраминидазе при гриппозной инфекции и вакцинации

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004161781A (ja) * 1992-03-03 2004-06-10 Dai Ichi Seiyaku Co Ltd 経口ワクチン
AUPQ846900A0 (en) * 2000-06-29 2000-07-27 Aruba International Pty Ltd A vaccine
JP2010512748A (ja) * 2006-12-15 2010-04-30 シェーリング−プラウ・リミテッド インフルエンザウイルスを培養物中で複製するための方法
TW200927928A (en) 2007-09-24 2009-07-01 Nobilon Internat B V Inactivated influenza vaccine
US20090110698A1 (en) * 2007-10-31 2009-04-30 Newport Laboratories, Inc. Method of determining vaccine compliance

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2428476C1 (ru) * 2010-06-21 2011-09-10 Учреждение Российской Академии Медицинских Наук Научно-исследовательский институт экспериментальной медицины Северо-западного отделения РАМН (НИИЭМ СЗО РАМН) Реассортантный штамм вируса гриппа rn 1/09-swine a(h7n1) для определения антител к нейраминидазе при гриппозной инфекции и вакцинации

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HIROSHI KIMURA et al., Interspecies transmission of influenza C virus between humans and pigs, Virus research, 1997, Vol.48, pp.71-79. *
MARGARET HESSEN, In the clinic. Influenzae, Annals of internal medicine, 03.11.2009, pp.1-16. *
MARGARET HESSEN, In the clinic. Influenzae, Annals of internal medicine, 03.11.2009, pp.1-16. HIROSHI KIMURA et al., Interspecies transmission of influenza C virus between humans and pigs, Virus research, 1997, Vol.48, pp.71-79. *

Also Published As

Publication number Publication date
WO2013112995A1 (en) 2013-08-01
RU2014134850A (ru) 2016-03-20
CA2862328C (en) 2021-08-31
CN104203972A (zh) 2014-12-10
MX2014009022A (es) 2015-03-03
EP2807184A1 (en) 2014-12-03
AU2013211833A2 (en) 2014-09-25
US20130195915A1 (en) 2013-08-01
NZ629378A (en) 2017-06-30
MX360831B (es) 2018-11-16
BR112014018278A2 (pt) 2019-04-02
JP6257529B2 (ja) 2018-01-10
CA2862328A1 (en) 2013-08-01
HK1201283A1 (en) 2015-08-28
JP2015506949A (ja) 2015-03-05
AU2013211833B2 (en) 2017-09-14
US9278999B2 (en) 2016-03-08
BR112014018278B1 (pt) 2023-01-17
AU2013211833A1 (en) 2014-09-18
PH12014501688A1 (en) 2014-10-20

Similar Documents

Publication Publication Date Title
Polatoğlu et al. COVID‐19 in early 2023: Structure, replication mechanism, variants of SARS‐CoV‐2, diagnostic tests, and vaccine & drug development studies
Aileni et al. Biotechnological perspectives to combat the COVID-19 pandemic: precise diagnostics and inevitable vaccine paradigms
TWI702293B (zh) 用於a型流感病毒及b型流感病毒檢測之方法
Possebon et al. A fast and cheap in-house magnetic bead RNA extraction method for COVID-19 diagnosis
CN114835778A (zh) 一种h9n2亚型aiv mhc b2限制性表位肽及其应用
JP6257529B2 (ja) インフルエンザｃウイルス及びワクチン
Fereidouni et al. Failure of productive infection of Mallards (Anas platyrhynchos) with H16 subtype of avian influenza viruses
CN118957165B (zh) 用于检测甲型流感病毒的探针组合、试剂盒及检测方法
Kareche et al. Equine influenza outbreak in Eastern of Algeria in 2021: The first introduction of Florida Clade 1 to Maghreb area
WO2021214766A1 (en) Methods of diagnosing viral infections and vaccines thereto
Al-Jaf et al. Rapid, inexpensive methods for exploring SARS CoV-2 D614G mutation
Patankar et al. Development of RT-PCR based diagnosis of SARS-CoV-2
RU2511440C2 (ru) Способ количественного определения фиксированного вируса бешенства штамма "москва 3253"
RU2464312C1 (ru) Реассортантный штамм вируса гриппа rn2/57-human a(h7n2) для определения антител к нейраминидазе при гриппозной инфекции и вакцинации
Qin et al. Subtyping animal influenza virus with general multiplex RT-PCR and Liquichip high throughput (GMPLex)
US20240327822A1 (en) Materials and methods to comprehensively define adaptive immune responses
RU2361924C1 (ru) Способ обнаружения вируса гриппа а подтипа h5n1
Aileni et al. Biotechnological perspectives to combat the COVID-19 pandemic: precise diagnostics and inevitable vaccine paradigms. Cells. 2022; 11: 1182
Hussin et al. An Overview of laboratory Diagnosis of Central Nervous System Viral Infections.
WO2016210097A1 (en) Novel equine parvovirus and uses thereof
Yang et al. Diagnosis of Ebola virus disease: progress and prospects
Taghizadeh et al. COVID-19; History, Taxonomy, and Diagnostic Molecular and Immunological Techniques
Kaore et al. Laboratory diagnosis of novel H1N1 virus
Eromon Comparative Assessment of SARS-CoV-2 Diagnostics in Nigeria
Maharjan Validation of Saliva Biospecimen: an alternative to Nasopharyngeal Swab for detection of SARS-CoV-2 using RT-PCR